Other
Intrauterine Insemination
0
Pipeline Programs↗
1
Active Trials↗
2
Companies Involved↗
Intrauterine Insemination is an early-stage landscape with 0 programs across 2 companies. The most active players are Ferring, Merck & Co..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
14
clinical trials
Completed11 · 79%
Unknown status1 · 7%
Terminated1 · 7%
Recruiting1 · 7%
Clinical Trials
Trial Activity
14 trials
Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauterine Successful Experience (RISE)
Recruiting·—·Phase 2·NCT07153367·80 enrolled
Study Evaluating the Timing of Intrauterine Insemination in Relation to Positive Home Ovulation Prediction Kit
Completed·—·N/A·NCT02294773·13 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)